ADMA 12.0000 Adma Biologics $ADMA Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 10:09 AM

ADMA 12.0000 Adma Biologics $ADMA Hit a 52 week high of 13.5300 Currently at 12.0000 -0.2500 -2.04% With a day low of 10.7400 and a total volume of 17,200.

ADMA Adma Biologics Recent Headline News

ADMA Biologics beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 7:14AM CST

ADMA: 12.0000 (-0.2500)

ADMA Biologics to Present at the 9th International Respiratory Syncytial Virus (RSV) Symposium
GlobeNewswire - Mon Nov 10, 6:38AM CST
ADMA Biologics, Inc. (Nasdaq:ADMA), announced today that it will be presenting data describing the composition and efficacy in an animal model of its polyclonal IVIG product, RI-002, at the 9th International Respiratory Syncytial Virus (RSV) Symposium, in Cape Town, South Africa. The abstract is titled: "Treatment of Normal and Immune Suppressed Cotton Rats with IVIG Containing High Titer Neutralizing Anti-RSV Antibody."
ADMA: 12.0000 (-0.2500)

ADMA Biologics Reports Third Quarter 2014 Financial and Operational Results
GlobeNewswire - Mon Nov 10, 6:08AM CST
ADMA Biologics, Inc. (Nasdaq:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported its financial and operational results for the third quarter ended September 30, 2014 and announced recent Company developments and anticipated milestones for the remainder of 2014.
ADMA: 12.0000 (-0.2500)

ADMA Biologics Approved for Trading on NASDAQ
GlobeNewswire - Wed Nov 05, 3:38PM CST
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that the NASDAQ stock market has approved ADMA's common stock for listing on the NASDAQ Capital Market and is expected to begin trading on November 10, 2014 under the symbol "ADMA."
ADMA: 12.0000 (-0.2500)

ADMA Biologics to Present "Ascending Company" Presentation at BioNJ CEO Summit
Business Wire - Thu Oct 16, 7:00AM CDT
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced it is scheduled to present at the BioNJ CEO Summit Conference at 9:30 AM ET on October 21, 2014 at the Bridgewater Marriott, in Bridgewater, New Jersey.
ADMA: 12.0000 (-0.2500)

ADMA Biologics' Plasma Collection Subsidiary ADMA BioCenters Norcross, GA Facility Expands Global Regulatory Approval Presence
Business Wire - Wed Sep 10, 7:00AM CDT
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that its wholly owned subsidiary, ADMA BioCenters in Norcross, Georgia, received approval from the Korean Ministry of Food and Drug Safety (MFDS) for the sale of source plasma into South Korea.
ADMA: 12.0000 (-0.2500)

ADMA Biologics Reports Second Quarter 2014 Financial and Operational Results
Business Wire - Mon Aug 11, 3:35PM CDT
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today reported its financial and operational results for the second quarter ended June 30, 2014 and announced recent company developments and anticipated milestones for 2014.
ADMA: 12.0000 (-0.2500)

ADMA Biologics Forms Scientific Advisory Board with Expertise in Immune Deficiencies, Infectious Diseases and Transplantation
Business Wire - Mon Jun 16, 7:00AM CDT
ADMA Biologics, Inc. (OTCQB: ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced the formation of its Scientific Advisory Board (SAB) with the following appointments: R. Michael Blaese, M.D., Roy F. Chemaly, M.D., M.P.H., John DeVincenzo, M.D., Richard O'Reilly, M.D., Jordan S. Orange, M.D., Ph.D., and E. Richard Stiehm, M.D.
ADMA: 12.0000 (-0.2500)

ADMA Biologics to Present at 9th Annual JMP Securities Healthcare Conference on June 24
Business Wire - Fri Jun 13, 3:15PM CDT
ADMA Biologics, Inc. (OTCQB: ADMA), a late stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that Adam Grossman, ADMA's President, Chief Executive Officer and founder, is scheduled to present a company overview at the conference on Tuesday, June 24, 2014 at 12:00 p.m. EDT, at The Westin New York Grand Central Hotel, New York, NY.
ADMA: 12.0000 (-0.2500)

ADMA Biologics to Present Company Overview at the 13th Annual Needham Healthcare Conference
Business Wire - Mon Mar 31, 6:30AM CDT
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced that Adam Grossman, ADMA's President, Chief Executive Officer and founder, is scheduled to present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014, at 8:00 a.m. EDT. The conference will be held from April 8-9, 2014 at The Westin New York Grand Central Hotel, New York, NY.
ADMA: 12.0000 (-0.2500)

ADMA Biologics Reports Year End 2013 Results
Business Wire - Fri Mar 28, 6:15AM CDT
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced its financial results for the year ended December 31, 2013 and provided recent company developments as well as anticipated milestones for 2014.
ADMA: 12.0000 (-0.2500)

ADMA Biologics Secures up to $15 Million Loan Commitment from Hercules Technology Growth Capital
Business Wire - Thu Feb 27, 7:00AM CST
ADMA Biologics, Inc. (OTCQB:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced it has secured a loan commitment for up to $15 million from Hercules Technology Growth Capital, Inc. (NYSE:HTGC), a leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related markets.
HTGC: 16.08 (-0.02), ADMA: 12.0000 (-0.2500)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dar Global Eyes Dubai for Strategic Real Estate Moves

Tapping into Dubai's Real Estate Allure Every seasoned investor knows the real estate game ain't for the faint of heart, especially when you’re playing in a market as competitive as Dubai's. But here comes Dar Global Capital Partners (DGCP), throwing their hat into the ring with a fresh strategy centered around high-value real estate. Sure, they aren't new to the...

Redwood and SAP Partner on Secure File Transfer

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

Bertram Capital Backs MCE's Expansive Growth Vision

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Minesto Teams Up to Unlock Tidal Power in Maldives

The world of ocean energy just got a jolt from an unlikely corner. Minesto, the ocean energy whiz, and Morteza Capital, a savvy investment force entrenched in the Maldives, are shaking hands to usher tidal energy into this paradise. Tidal Waves Meet Tourism When you're talking about the Maldives, you're talking about two main things: pristine tropical getaways and a whole...

Blue Ridge Bankshares Q3 2026 Earnings: Challenges Ahead

Crunching the Numbers at Blue Ridge Bankshares Sometimes the market throws curveballs, and it seems Blue Ridge Bankshares, Inc. is caught in a tricky inning this third quarter of 2026. With a reported net loss of $4.2 million or ($0.05) per diluted share, it certainly doesn't paint a rosy picture compared to a year prior. This ain't no cocktail brunch chatter—this is...

Cleveland Youth Team Uses Global Catch for Fundraising

Turning a Simple Game into a Global Campaign Sometimes, you just need a fresh angle to hit a home run, and that's what Thunder Baseball is counting on. The Cleveland-based 501(c)(3) youth baseball organization is ditching the old fundraising playbook. No more cookie-cutter raffles or bake sales. Instead, they’re launching a campaign that taps into the universal joy of...

Canton Fair 2026: Tech and Tradition Transform Jewelry

Tech-Savvy Elegance at Canton Fair Dive into the glitz and glamour of the jewelry zone at the 140th Canton Fair, where technology and craftsmanship are forging a new narrative for luxury accessories. This isn’t just your grandmother’s jewelry box we're talking about anymore. We’re witnessing the dawn of precious metal smart rings and dual-band smart watches that...

Pizza & Hope: Little Caesars Serves WV Communities

Rolling Out Dough and Kindness in West Virginia In a world that's more uncertain than a penny stock, here comes a story that'll warm even the coldest heart: Little Caesars is sending their Love Kitchen into West Virginia, aiming to serve piping hot pizza to about 8,000 folks in need. Fueled by the efforts of local franchisee Vicki Dunn-Marshall and her team, they're...

CEO Transition at Hahn & Hahn Brings New Leadership Era

Leadership Change at Hahn & Hahn LLP I'll tell you what: When a legal powerhouse like Hahn & Hahn LLP decides to mix things up at the top, folks have got to pay attention. Jumping ship is Christianne Kerns, stepping down from her dual role as CEO and Managing Partner, while Rita Diaz gears up to fill those shoes come January 1, 2027. This ain't just some casual...

Golden Bear Faces Wage Violation Class Action Case

Legal Battle Brewing in Merced Well, folks, looks like Golden Bear Physical Therapy Sports Injury Center, Inc. is in for a bumpy ride. The company is facing a whopper of a class action lawsuit, filed by the folks over at Blumenthal Nordrehaug Bhowmik De Blouw LLP, alleging violations of the California Labor Code. This legal skirmish is unfolding right there in the Merced...